Hepatic Vein Flow During Orthotopic Liver Transplantation as Predictive Factor for Postoperative Graft Function

NCT03814031 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 97

Last updated 2024-09-23

Study results available
· View outcomes & findings →

Summary

Hepatic vein flow (HVF) assessment using transesophageal echocardiography (TEE) has a potential to predict postoperative graft function in orthotopic liver transplant (OLT). Investigators will measure HVF using TEE and assess the correlation with postoperative graft function indices such as early allograft dysfunction(EAD), prolonged INR, platelet, and total bilirubin.

Conditions

  • Postoperative Graft Function

Interventions

OTHER

NO internvention

NO internvention

Sponsors & Collaborators

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Yoshihisa Morita, MD · Henry Ford Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-20
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03814031 on ClinicalTrials.gov